Namestemovate E
Namestemovate E Uses, Dosage, Side Effects, Food Interaction and all others data.
Namestemovate E is under investigation for the treatment of Scleroderma. Namestemovate E has been investigated for the prevention of Psoriasis and Cutaneous Atrophy Due to Corticosteroids.
Trade Name | Namestemovate E |
Availability | Prescription only |
Generic | Clobetasol |
Clobetasol Other Names | Clobetasol |
Related Drugs | Humira, Cosentyx, Dupixent, prednisone, doxycycline, methotrexate, betamethasone topical, Remicade, Stelara, cyclosporine |
Type | |
Formula | C22H28ClFO4 |
Weight | Average: 410.907 Monoisotopic: 410.166015296 |
Groups | Approved, Experimental, Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | United States |
Last Updated: | September 19, 2023 at 7:00 am |
Namestemovate E Disease Interaction
Moderate: diabetes, diaper rash, hyperadrenocorticism, infections, ocular toxicities
Innovators Monograph
You find simplified version here Namestemovate E